Production of TGFβ by radio-treated CAFs can also promote cancer cell aggressive and invasive properties, acting as a radiotherapy therapeutic escape and resistance (Papadopoulou and Kletsas, 2011; Zhang et al., 2017). The gene discussed is TGFB1; the disease is cancer.